FDA Inspection 669685 — Glenmark Pharmaceuticals Inc., USA

Glenmark Pharmaceuticals Inc., USA — FEI 3005658103

The FDA completed an inspection of Glenmark Pharmaceuticals Inc., USA on Jun 29, 2010 in Elmwood Park, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 29, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Elmwood Park, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
241921 CFR 211.198(a)Complaint Handling Procedure
673021 CFR 314.80(b)Failure to develop written procedures
683121 CFR 314.80(c)(2)Late submission of quarterly safety reports

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.